Business Context and Reporting Period
This Form 8-K is a current report filed by Marathon Petroleum Corporation on September 29, 2011, with the earliest event reported dated October 1, 2011. The filing addresses the amendment of a material definitive agreement regarding an accounts receivable securitization facility and the adoption of a corporate governance position statement regarding stockholder rights plans.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, or liquidity ratios. The primary financial instrument discussed is a $1 billion accounts receivable securitization facility (the "A/R Facility").
Material Changes
- Amendment of A/R Facility: On October 1, 2011, the Company entered into amended and restated agreements to modify its existing $1 billion A/R Facility. The amendment expands the facility to include trade receivables originated by Marathon Petroleum Trading Canada LLC, a wholly-owned subsidiary.
- Stockholder Rights Plan Policy: On September 29, 2011, the Board of Directors adopted a formal position statement confirming that the Company does not currently have a "poison pill" or stockholder rights plan in place.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, earnings outlook, or management commentary regarding future operational performance. Regarding the stockholder rights plan, the Board stated that if a plan is adopted in the future, it will be done by a majority of independent directors. The Board intends to seek prior stockholder approval unless time constraints dictate otherwise. If adopted without prior approval, the plan would expire after one year unless ratified by stockholders.
Investor Verification Checklist
- Verify the specific criteria, limitations, and reserves applied to the trade receivables from Marathon Petroleum Trading Canada LLC within the amended A/R Facility.
- Review the full text of the Amended and Restated Receivables Purchase Agreement (Exhibit 10.1) and Sale Agreement (Exhibit 10.2) for detailed terms.
- Confirm the current status of the $1 billion facility and any utilization levels, as this filing only details the structural amendment.
- Monitor future Board actions regarding the potential adoption of a stockholder rights plan, noting the requirement for annual review of the position statement.